CSL Annual Report 2026

Notes to the Financial Statements Retain and Grow Plan (RGP) Executive Performance and Alignment Plan (EPA) Non-Executive Director Plan (NED) Global Employee Share Plan (GESP) Total Number Weighted average exercise price (A$) Number Weighted average exercise price (A$) Number Weighted average exercise price (A$) Number Weighted average exercise price (A$) Number Outstanding at beginning of year 1,504,879 — 602,365 — 1,396 — 151,228 203.56 2,259,868 Granted during year 1,349,153 — 361,590 — 4,325 — 384,665 109.30 2,099,733 Exercised during year (771,090) — (69,088) — (2,531) — (318,046) (152.12) (1,160,755) Forfeited during year (273,019) — (199,204) — (410) — — — (472,633) GESP true-up — — — — — — (743) 203.56 (743) Closing balance at end of year 1,809,923 — 695,663 — 2,780 — 217,104 97.53 2,725,470 The share price at the dates of exercise (expressed as a weighted average) by equity instrument type, is as follows: 2026 2025 RGP A$206.58 A$303.80 EPA A$210.27 A$307.14 NED A$181.89 A$283.43 GESP A$178.02 A$279.38 b. Key Management Personnel Disclosures The remuneration of key management personnel is in Section 10 of the Directors’ Report and has been audited. Total compensation for key management personnel 2026 2025 US$ US$ Total of short term remuneration elements 5,775,103 10,304,999 Total of post-employment elements 233,145 384,100 Total of other long term elements 72,096 23,368 Total share-based payments (816,832) 7,944,730 Total termination payments 1,823,455 — Total of all remuneration elements 7,086,967 18,657,197 108 108 Financial Report

RkJQdWJsaXNoZXIy MjE2NDg3